Advertisement
Insights in the wake of a large international registry study
An expert Q&A on degeneration findings from EuroPCR
Median treatment time trimmed to 52 minutes
Case shows why vigilance for stenosis is imperative
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Perspectives from leading Cleveland Clinic co-investigators
Risk factors surge as patients grow younger, more obese
FDA approvals for valve-in-valve TAVR follow clearance of 3rd-generation valve
New device looks to be a vital second-line therapy for selected patients
Changes save time and money and reduce stress
Percutaneous aortic and mitral approaches proliferate
Advertisement
Advertisement